Anteris Technologies Global Corp. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
AVR Nasdaq 3850 anteristech.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anteris Technologies Global Corp.

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV - Mar 31st, 2025 11:15 am
Anteris Reports One-Year Patient Outcomes for DurAVR® THV - Mar 21st, 2025 11:30 am
Anteris Reports 2024 Financial Results and Provides Corporate Update - Mar 13th, 2025 12:33 am
Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays - Feb 28th, 2025 1:00 pm
Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering - Dec 17th, 2024 12:49 am
Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering - Dec 13th, 2024 3:34 am